Results 11 to 20 of about 6,519 (211)
Endocrine Connections, 2021 Objective: To investigate the relationship between serum uric acid (SUA) level and renal outcome in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). Methods: A total of 393 Chinese patients with T2DM and biopsy-proven DN and
Yutong Zou +16 more
doaj +1 more source
The Vascular Disease of Diabetic Kidney Disease
Cardiorenal Medicine, 2022 <b><i>Background:</i></b> The incidence of cardiovascular disease (CVD) is increased in patients with diabetic kidney disease (DKD). <b><i>Summary:</i></b> Aortic stiffness is a well-accepted biomarker for cardiovascular (CV) events in all stages of CKD.
Paolo Lentini +9 more
openaire +4 more sources
Mitophagy in Diabetic Kidney Disease [PDF]
Frontiers in Cell and Developmental Biology, 2021 Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease worldwide and is the main microvascular complication of diabetes. The increasing prevalence of diabetes has increased the need for effective treatment of DKD and identification of new therapeutic targets for better clinical management.
Xiaofeng Zhang +6 more
openaire +3 more sources
Renal Failure, 2022 We aimed to determine the utility of biopsy data and anemia for the prediction of renal outcomes in Chinese patients with type 2 diabetes. In total, 441 Chinese patients with type 2 diabetes and biopsy-confirmed diabetic nephropathy (DN) were enrolled in
Lijun Zhao +16 more
doaj +1 more source
Mitochondria in Diabetic Kidney Disease [PDF]
Cells, 2021 Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, tubular atrophy, and interstitial inflammation and ...
Amna Ayesha Ahmad +2 more
openaire +3 more sources
Student's Journal of Health Research Africa, 2023 Background: Diabetic and chronic kidney disease together tend to worsen the outcomes. A newer approach to treat both the comorbid disease can slow down the prognosis of both the disease leading to quality of life.
Surendra Prasad Singh
doaj +1 more source
A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain
BMC Nephrology, 2018 Background The end stage renal disease population has a 20 fold higher incidence of cardiovascular mortality compared to the overall population. The development of reno-cardiac syndrome in these patients will result in cardiovascular events to be the ...
Julius E. Kieswich +6 more
doaj +1 more source
BMC Nephrology, 2023 Background Diabetic kidney disease (DKD) is the most common microvascular complication of diabetes, which has been a major cause of end-stage renal failure.
Xue-hong Zhou +4 more
doaj +1 more source
Pathophysiology of Diabetic Kidney Disease
European Medical Journal Nephrology, 2022 Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease worldwide. DKD involves various intersecting pathways that lead to progressive kidney damage.
Moarij Qaz +4 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials.
Qiaoru Wu +8 more
doaj +1 more source